{
    "nctId": "NCT05141279",
    "briefTitle": "Accuracy Of Contrast Enhanced Mamography in Predicting Response of Breast Cancer Post Neoadjuvant Chemotherapy",
    "officialTitle": "Contrast Enhanced Mamography in Predicting Response of Breast Cancer Post Neoadjuvant Chemotherapy",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "Accuracy of contrast enhanced spectral mamography in the predicting of pathological response to NAC and assessment residual disease in breast cancer patients",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* patient confirmed diagnosed by early breast cancer decided to received neoadjuvant treatment\n* locally advanced breast cancer\n* operable metastatic breast cancer\n\nExclusion Criteria:\n\n* patient not candidate for NAC\n* contrast allergy\n* renal impairment\n* pregnancy",
    "sex": "ALL",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}